68 related articles for article (PubMed ID: 31380881)
21. Novel Fucoidan Pharmaceutical Formulations and Their Potential Application in Oncology-A Review.
Zahariev N; Katsarov P; Lukova P; Pilicheva B
Polymers (Basel); 2023 Jul; 15(15):. PubMed ID: 37571136
[TBL] [Abstract][Full Text] [Related]
22. Magnetite Nanoparticles in Magnetic Hyperthermia and Cancer Therapies: Challenges and Perspectives.
Włodarczyk A; Gorgoń S; Radoń A; Bajdak-Rusinek K
Nanomaterials (Basel); 2022 May; 12(11):. PubMed ID: 35683663
[TBL] [Abstract][Full Text] [Related]
23. Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance.
Chu S; Stochaj U
Cancer Drug Resist; 2020; 3(3):302-333. PubMed ID: 35582453
[TBL] [Abstract][Full Text] [Related]
24. Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles.
Abed A; Derakhshan M; Karimi M; Shirazinia M; Mahjoubin-Tehran M; Homayonfal M; Hamblin MR; Mirzaei SA; Soleimanpour H; Dehghani S; Dehkordi FF; Mirzaei H
Front Pharmacol; 2022; 13():797804. PubMed ID: 35281900
[TBL] [Abstract][Full Text] [Related]
25. Targeting Engineered Nanoparticles for Breast Cancer Therapy.
Ganesan K; Wang Y; Gao F; Liu Q; Zhang C; Li P; Zhang J; Chen J
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834243
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Antioxidant Capacities of Antarctic Macroalgae and Their Use for Nanoparticles Production.
González-Ballesteros N; Rodríguez-Argüelles MC; Lastra-Valdor M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672102
[TBL] [Abstract][Full Text] [Related]
27. Red Blood Cell Membrane-Coated Silica Nanoparticles Codelivering DOX and ICG for Effective Lung Cancer Therapy.
Xiao J; Weng J; Wen F; Ye J
ACS Omega; 2020 Dec; 5(51):32861-32867. PubMed ID: 33403246
[TBL] [Abstract][Full Text] [Related]
28. Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy.
Wang JY; Song YQ; Peng J; Luo HL
ACS Omega; 2020 Sep; 5(36):22840-22846. PubMed ID: 32954132
[TBL] [Abstract][Full Text] [Related]
29. Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance.
Reyes ME; Riquelme I; Salvo T; Zanella L; Letelier P; Brebi P
Mar Drugs; 2020 Apr; 18(5):. PubMed ID: 32354032
[TBL] [Abstract][Full Text] [Related]
30. The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.
Jin JO; Chauhan PS; Arukha AP; Chavda V; Dubey A; Yadav D
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34068561
[TBL] [Abstract][Full Text] [Related]
31. "Fucoidan, a natural biopolymer in cancer combating: From edible algae to nanocarrier tailoring".
Etman SM; Elnaggar YSR; Abdallah OY
Int J Biol Macromol; 2020 Mar; 147():799-808. PubMed ID: 31770552
[TBL] [Abstract][Full Text] [Related]
32. Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells.
Kang S; Kang K; Chae A; Kim YK; Jang H; Min DH
Nanoscale; 2019 Aug; 11(32):15173-15183. PubMed ID: 31380881
[TBL] [Abstract][Full Text] [Related]
33. Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy.
Fu B; Dang M; Tao J; Li Y; Tang Y
J Colloid Interface Sci; 2020 Jun; 570():197-204. PubMed ID: 32151829
[TBL] [Abstract][Full Text] [Related]
34. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
35. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]